Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 6/2010

01-12-2010 | Letter to the Editor

Comments on the letter “Fertility preservation and GnRHa for chemotherapy: debate”

Authors: Michael von Wolff, Juliane Raddatz, Michael K. Bohlmann, Petra Stute, Thomas Strowitzki, Markus Nitzschke

Published in: Archives of Gynecology and Obstetrics | Issue 6/2010

Login to get access

Excerpt

Thank you very much for the critical comments. Any critical comment on the use of GnRH analogs (GnRHa) to protect fertility during chemotherapy is of great value in further discussions of the controversial data and the controversial attitudes of endocrinologists and ocologists. …
Literature
1.
go back to reference Blumenfeld Z, von Wolff M (2008) GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14:543–552CrossRefPubMed Blumenfeld Z, von Wolff M (2008) GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14:543–552CrossRefPubMed
2.
go back to reference von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, Salle B, Sonmezer M, Andersen CY (2009) Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy—a technique in its infancy but already successful in fertility preservation. Eur J Cancer 45:1547–1553CrossRef von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, Salle B, Sonmezer M, Andersen CY (2009) Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy—a technique in its infancy but already successful in fertility preservation. Eur J Cancer 45:1547–1553CrossRef
3.
go back to reference Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553–561CrossRefPubMed Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553–561CrossRefPubMed
4.
go back to reference Badawy A, Elnashar A, El-Ashry M, Shahat M (2009) Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 9:694–697CrossRef Badawy A, Elnashar A, El-Ashry M, Shahat M (2009) Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 9:694–697CrossRef
5.
go back to reference Ismail-Khan R, Minton S, Cox C et al (2008) Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using GnRH agonist (triptoreline) during chemotherapy. J Clin Oncol 26(Suppl 1):12s Abstract 524 Ismail-Khan R, Minton S, Cox C et al (2008) Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using GnRH agonist (triptoreline) during chemotherapy. J Clin Oncol 26(Suppl 1):12s Abstract 524
6.
go back to reference Gerber B, Dieterich M (2010) Ovarielle Protektion unter Chemotherapie durch GnRH-Agonisten. Gynäkologische Endokrinologie 1:41–46CrossRef Gerber B, Dieterich M (2010) Ovarielle Protektion unter Chemotherapie durch GnRH-Agonisten. Gynäkologische Endokrinologie 1:41–46CrossRef
7.
go back to reference Behringer K, Wildt L, Mueller H, Mattle V, Ganitis P, van den Hoonaard B, Ott HW, Hofer S, Pluetschow A, Diehl V, Engert A, Borchmann P, on behalf of the German Hodgkin Study Group (2010) No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol. doi:10.1093/annonc/mdq066 Behringer K, Wildt L, Mueller H, Mattle V, Ganitis P, van den Hoonaard B, Ott HW, Hofer S, Pluetschow A, Diehl V, Engert A, Borchmann P, on behalf of the German Hodgkin Study Group (2010) No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol. doi:10.​1093/​annonc/​mdq066
8.
go back to reference von Wolff M, Zeeb C, Lawrenz B, Germeyer A., Neunhoeffer E, Strowitzki T (2009) Cryopreservation of ovarian tissue and cryopreservation of oocytes can be efficiently combined and performed within 2 weeks before chemotherapy. Hum Reprod 24(1) Abstract Book P-392 von Wolff M, Zeeb C, Lawrenz B, Germeyer A., Neunhoeffer E, Strowitzki T (2009) Cryopreservation of ovarian tissue and cryopreservation of oocytes can be efficiently combined and performed within 2 weeks before chemotherapy. Hum Reprod 24(1) Abstract Book P-392
9.
go back to reference von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T (2009) Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 92:1360–1365CrossRef von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T (2009) Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 92:1360–1365CrossRef
10.
go back to reference Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K (2007) Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 92:2197–2200CrossRefPubMed Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K (2007) Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 92:2197–2200CrossRefPubMed
Metadata
Title
Comments on the letter “Fertility preservation and GnRHa for chemotherapy: debate”
Authors
Michael von Wolff
Juliane Raddatz
Michael K. Bohlmann
Petra Stute
Thomas Strowitzki
Markus Nitzschke
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 6/2010
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1486-1

Other articles of this Issue 6/2010

Archives of Gynecology and Obstetrics 6/2010 Go to the issue